The partnership between Koble and Maple will provide much-needed support for an underserved group – new and expecting parents.
ORIGINAL PRESS RELEASE, PR Newswire, September 21, 2022 Adapsyn Bioscience Inc., a chemical bioinformatics company
Eye3 has gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.
Original Press Release, Yahoo Finance, September 21, 2022 NORTH BRUNSWICK, N.J., Sept. 21, 2022 —
Take a listen to our latest podcast as Rachel Bartholomew, CEO and Founder of Hyivy Health shares her medical device commercialization journey.
Hamilton, Ontario, a long-standing leader in health and life science research and innovation, was recently
Swati Matta, CEO & Founder of Koble, shares her startup journey and POV on the challenges of being a woman in the tech industry.
ORIGINAL PRESS RELEASE, Nicole Estrin, Innovative Health Diagnostics, August 16, 2022 Both laboratories join forces
ORIGINAL ARTICLE, Ritika Dubey, The Hamilton Spectator, July 26, 2022 Q and A: Dr. Harald Stover
Medtech startup Cosm Medical has secured $4.7 million CAD to create custom medical devices for women suffering from pelvic floor disorders.
ORIGINAL ARTICLE – Mohawk College, March 10, 2022 Is your tetanus shot still up to
Press Release: HyIvy Health Hyivy Health’s innovative pelvic health rehabilitation system looks to provide a
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Learn how Swift Medical is reshaping the way wounds are imaged for diagnosis with AI and data-driven technology.
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Southern Ontario Pharmaceutical & Health Innovation Ecosystem (SOPHIE) Program brings together Innovation Factory’s commercialization services with the Synapse Life Science Consortium’s strategic network to leverage access to Hamilton’s unique life sciences capabilities and research expertise.
